Our proprietary systems are designed to substantially reduce both the time and costs presently expended for screening drug candidates for both efficacy and toxicity.  These cell-based technologies provide a rapid and efficient method by  which multiple simultaneous bio-optical cellular signals are continuously tracked on a millisecond time scale and analyzed in real-time.  This analysis yields a “fingerprint” of the complex cellular mechanisms induced by the drug candidate.  The specificity, sensitivity, and toxicological profile are derived using proprietary bioinformatic database.